$ 8.50 · 4.8 (637) · In stock
Extensive damage to skeletal muscle tissue due to volumetric muscle loss (VML) is beyond the inherent regenerative capacity of the body, and results in permanent functional debilitation. Current clinical treatments fail to fully restore native muscle function. Recently, cell-based therapies have emerged as a promising approach to promote skeletal muscle regeneration following injury and/or disease. Stem cell populations, such as muscle stem cells, mesenchymal stem cells and induced pluripotent stem cells (iPSCs), have shown a promising capacity for muscle differentiation. Support cells, such as endothelial cells, nerve cells or immune cells, play a pivotal role in providing paracrine signaling cues for myogenesis, along with modulating the processes of inflammation, angiogenesis and innervation. The efficacy of cell therapies relies on the provision of instructive microenvironmental cues and appropriate intercellular interactions. This review describes the recent developments of cell-based therapies for the treatment of VML, with a focus on preclinical testing and future trends in the field.
Bioengineering, Free Full-Text, cross check in a sentence
Best Master's in Biomedical Engineering Degree Programs of 2023
Bioengineering, Free Full-Text, cross check in a sentence
Bioengineering, Free Full-Text
Biomedical Engineering MEng, Study
Bioengineering and Biotechnology, Free Online Course
Bioengineering, Free Full-Text
Bioengineering, Free Full-Text
Emily, Haleigh author new paper from the lab In Nature Materials
PDF) Label-free microfluidic sorting of microparticles
Claire Holt parties after ex-husband proposes to Alex Cooper, claire holt
Journal of Bioscience and Bioengineering
Biomedical Engineering Images – Browse 32,566 Stock Photos
The Preclinical And Clinical Progress Of Cell Sheet, 41% OFF